Table of Content

1 Meningococcal Infections Vaccine Market Introduction and Overview
1.1 Meningococcal Infections Vaccine Definition
1.2 Research Purposes
1.3 Report Timeline
1.4 Economic Analysis of Global Regions
1.5 Inflation Analysis
1.6 The Impact of the Russian-Ukrainian War on the Market
1.7 Coronavirus Disease 2020 (COVID-19) Impact on Global
2 Global Meningococcal Infections Vaccine Historical Market Analysis by Type
2.1 Market Size Analysis by Types
2.2 Global Meningococcal Infections Vaccine Revenue and Market Share by Type
3 Global Meningococcal Infections Vaccine Historical Market Analysis by Application
3.1 Market Size Analysis by Application
3.2 Global Meningococcal Infections Vaccine Revenue Market Share by Application (2019-2024)
4 Global Market Growth Trends Analysis
4.1 Global Meningococcal Infections Vaccine Market Size (2019-2024)
4.2 Meningococcal Infections Vaccine Growth Trends Analysis by Regions
4.2.1 Meningococcal Infections Vaccine Market Size by Regions: 2019 VS 2024 VS 2030
4.2.2 Meningococcal Infections Vaccine Historic Revenue Market Size by Regions (2019-2024)
4.2.3 North America Meningococcal Infections Vaccine Market Size (2019-2024)
4.2.4 Europe Meningococcal Infections Vaccine Market Size (2019-2024)
4.2.5 Asia-Pacific Meningococcal Infections Vaccine Market Size (2019-2024)
4.2.6 Latin America Meningococcal Infections Vaccine Market Size (2019-2024)
4.2.7 Middle East & Africa Meningococcal Infections Vaccine Market Size (2019-2024)
5 North America
5.1 North America Meningococcal Infections Vaccine Revenue by Countries
5.1.1 North America Meningococcal Infections Vaccine Revenue by Countries (2019-2024)
5.2 North America Meningococcal Infections Vaccine Revenue by Types
5.3 North America Meningococcal Infections Vaccine Revenue by Applications
5.4 United States
5.5 Canada
6 Asia Pacific
6.1 Asia Pacific Meningococcal Infections Vaccine Revenue by Countries
6.1.1 Asia Pacific Meningococcal Infections Vaccine Revenue by Countries (2019-2024)
6.2 Asia Pacific Meningococcal Infections Vaccine Revenue by Types
6.3 Asia Pacific Meningococcal Infections Vaccine Revenue by Applications
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Meningococcal Infections Vaccine Revenue by Countries
7.1.1 Europe Meningococcal Infections Vaccine Revenue by Countries (2019-2024)
7.2 Europe Meningococcal Infections Vaccine Revenue by Types
7.3 Europe Meningococcal Infections Vaccine Revenue by Applications
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Spain
7.10 Nordic
8 Latin America
8.1 Latin America Meningococcal Infections Vaccine Revenue by Countries
8.1.1 Latin America Meningococcal Infections Vaccine Revenue by Countries (2019-2024)
8.2 Latin America Meningococcal Infections Vaccine Revenue by Types
8.3 Latin America Meningococcal Infections Vaccine Revenue by Applications
8.4 Brazil
8.5 Argentina
8.6 Mexico
9 Middle East & Africa
9.1 Middle East & Africa Meningococcal Infections Vaccine Revenue by Countries
9.1.1 Middle East & Africa Meningococcal Infections Vaccine Revenue by Countries (2019-2024)
9.2 Middle East & Africa Meningococcal Infections Vaccine Revenue by Types
9.3 Middle East & Africa Meningococcal Infections Vaccine Revenue by Applications
9.4 Egypt
9.5 South Africa
9.6 UAE
9.7 Turkey
9.8 Saudi Arabia
10 Global Meningococcal Infections Vaccine Market Competition, by Players
10.1 Global Meningococcal Infections Vaccine Revenue and Market Share by Players
10.2 Market Concentration Rate
10.2.1 Top 3 Meningococcal Infections Vaccine Players Market Share in 2023
10.2.2 Top 6 Meningococcal Infections Vaccine Players Market Share in 2023
10.2.3 Market Competition Trend
10.3 Meningococcal Infections Vaccine Players Head Office, Business Provided
10.4 Meningococcal Infections Vaccine Mergers & Acquisitions
10.5 Meningococcal Infections Vaccine New Entrants and Expansion Plans
11 Players Profiles11.1 Sanofi-Pasteur
11.1.1 Sanofi-Pasteur Company Profile
11.1.2 Meningococcal Infections Vaccine Product Overview
11.1.3 Sanofi-Pasteur Meningococcal Infections Vaccine Market Performance (2019-2024)
11.1.4 Sanofi-Pasteur Business Overview
11.1.5 Recent Developments and Plans
11.2 Beijing Tiantan Biological Products
11.2.1 Beijing Tiantan Biological Products Company Profile
11.2.2 Meningococcal Infections Vaccine Product Overview
11.2.3 Beijing Tiantan Biological Products Meningococcal Infections Vaccine Market Performance (2019-2024)
11.2.4 Beijing Tiantan Biological Products Business Overview
11.2.5 Recent Developments and Plans
11.3 Shanghai Institute of Biological Products
11.3.1 Shanghai Institute of Biological Products Company Profile
11.3.2 Meningococcal Infections Vaccine Product Overview
11.3.3 Shanghai Institute of Biological Products Meningococcal Infections Vaccine Market Performance (2019-2024)
11.3.4 Shanghai Institute of Biological Products Business Overview
11.3.5 Recent Developments and Plans
11.4 Wuhan Institute of Biological Products
11.4.1 Wuhan Institute of Biological Products Company Profile
11.4.2 Meningococcal Infections Vaccine Product Overview
11.4.3 Wuhan Institute of Biological Products Meningococcal Infections Vaccine Market Performance (2019-2024)
11.4.4 Wuhan Institute of Biological Products Business Overview
11.4.5 Recent Developments and Plans
11.5 Lanzhou Institute of Biological Products
11.5.1 Lanzhou Institute of Biological Products Company Profile
11.5.2 Meningococcal Infections Vaccine Product Overview
11.5.3 Lanzhou Institute of Biological Products Meningococcal Infections Vaccine Market Performance (2019-2024)
11.5.4 Lanzhou Institute of Biological Products Business Overview
11.5.5 Recent Developments and Plans
11.6 Hualan Biological Engineering
11.6.1 Hualan Biological Engineering Company Profile
11.6.2 Meningococcal Infections Vaccine Product Overview
11.6.3 Hualan Biological Engineering Meningococcal Infections Vaccine Market Performance (2019-2024)
11.6.4 Hualan Biological Engineering Business Overview
11.6.5 Recent Developments and Plans
11.7 Chongqing Zhifei Biological Products
11.7.1 Chongqing Zhifei Biological Products Company Profile
11.7.2 Meningococcal Infections Vaccine Product Overview
11.7.3 Chongqing Zhifei Biological Products Meningococcal Infections Vaccine Market Performance (2019-2024)
11.7.4 Chongqing Zhifei Biological Products Business Overview
11.7.5 Recent Developments and Plans
11.8 Zhejiang Tianyuan Bio-Pharmaceutical
11.8.1 Zhejiang Tianyuan Bio-Pharmaceutical Company Profile
11.8.2 Meningococcal Infections Vaccine Product Overview
11.8.3 Zhejiang Tianyuan Bio-Pharmaceutical Meningococcal Infections Vaccine Market Performance (2019-2024)
11.8.4 Zhejiang Tianyuan Bio-Pharmaceutical Business Overview
11.8.5 Recent Developments and Plans
11.9 Walvax Biotechnology
11.9.1 Walvax Biotechnology Company Profile
11.9.2 Meningococcal Infections Vaccine Product Overview
11.9.3 Walvax Biotechnology Meningococcal Infections Vaccine Market Performance (2019-2024)
11.9.4 Walvax Biotechnology Business Overview
11.9.5 Recent Developments and Plans
12 Global Meningococcal Infections Vaccine Forecast Market Analysis by Type
12.1 Global Meningococcal Infections Vaccine Revenue Market Forecast by Type (2024-2030)
13 Global Meningococcal Infections Vaccine Forecast Market Analysis by Application
13.1 Meningococcal Infections Vaccine Revenue Market Forecast by Application (2024-2030)
14 Global Market Growth Forecast Analysis
14.1 Global Meningococcal Infections Vaccine Forecast Market Size (2024-2030)
14.2 Meningococcal Infections Vaccine Growth Trends Forecast Analysis by Regions
14.2.1 Meningococcal Infections Vaccine Revenue Forecast Market Size by Regions (2024-2030)
14.2.2 North America Meningococcal Infections Vaccine Forecast Market Size (2024-2030)
14.2.3 Europe Meningococcal Infections Vaccine Forecast Market Size (2024-2030)
14.2.4 Asia-Pacific Meningococcal Infections Vaccine Forecast Market Size (2024-2030)
14.2.5 Latin America Meningococcal Infections Vaccine Forecast Market Size (2024-2030)
14.2.6 Middle East & Africa Meningococcal Infections Vaccine Forecast Market Size (2024-2030)
15 Meningococcal Infections Vaccine Industry Dynamic Analysis
15.1 Meningococcal Infections Vaccine Market Trends Analysis
15.2 Meningococcal Infections Vaccine Market Drivers Analysis
15.3 Meningococcal Infections Vaccine Market Challenges Analysis
15.4 Meningococcal Infections Vaccine Market Restraints Analysis